Login

Financial Snapshot

Revenue
TTM
$19.69M
Gross Margin
TTM
47.58%
Net Income
TTM
-$31.02M
Current Assets
2023 Q2
Current Liabilities
2023 Q2
Current Ratio
2023 Q2
5.69%
Total Assets
2023 Q2
Total Liabilities
2023 Q2
Book Value
2023 Q2
$52.64M
Cash
2023 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$1.124M

Stock Price

Loading...
Market Cap: $701.81

About Item 9 Labs Corp.

Item 9 Labs Corp. is a vertically integrated cannabis operator and dispensary franchisor. The company is headquartered in Phoenix, Arizona and currently employs 97 full-time employees. The company went IPO on 2011-11-03. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The firm also offers a dispensary franchise model through the national Unity Rd. retail brand. The firm offers approximately 75 active cannabis strains and more than 150 differentiated cannabis vaporizer (vape) products, as well as premium concentrates and Orion vape technologies. The firm's Item 9 Labs brand specializes in select products and user experience across several cannabis categories. The firm operates through two segments: Cultivation and Franchising. Its product lines include Item 9 Labs Flower, Item 9 Labs Concentrates, and Orion 710.

Industry: Dental Equipment & Supplies Peers: DMK PHARMACEUTICALS Corp ALIMERA SCIENCES INC Cognition Therapeutics Inc Hepion Pharmaceuticals Inc Cumberland Pharmaceuticals Inc Endexx Corp Johnson & Johnson Lipocine Inc Zynerba Pharmaceuticals, Inc.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support